Myriad Genetics, Inc.
MYGN
$8.18
$0.141.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -330.50M | -100.00K | -42.50M | -22.10M | -36.70M |
| Total Depreciation and Amortization | 14.10M | 14.40M | 14.80M | 15.60M | 15.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 329.80M | -18.50M | 58.50M | 14.50M | 26.50M |
| Change in Net Operating Assets | -27.00M | -12.10M | -24.20M | -7.30M | -2.30M |
| Cash from Operations | -13.60M | -16.30M | 6.60M | 700.00K | 2.60M |
| Capital Expenditure | -2.80M | -5.30M | -3.60M | -3.50M | -5.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 8.80M | -- |
| Other Investing Activities | -4.10M | -3.00M | -2.30M | 2.20M | -1.20M |
| Cash from Investing | -6.90M | -8.30M | -5.90M | 7.50M | -6.40M |
| Total Debt Issued | 0.00 | 40.00M | 20.00M | 20.00M | 20.00M |
| Total Debt Repaid | -100.00K | -20.60M | -19.60M | -20.10M | -20.10M |
| Issuance of Common Stock | 2.70M | -- | 2.90M | 0.00 | 3.00M |
| Repurchase of Common Stock | 0.00 | -5.80M | -1.20M | -3.00M | -500.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.60M | 13.60M | 2.10M | -3.10M | 2.40M |
| Foreign Exchange rate Adjustments | 600.00K | 100.00K | -700.00K | 1.20M | -700.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 2.30M | -2.30M |
| Net Change in Cash | -17.30M | -10.90M | 2.10M | 8.60M | -4.40M |